Drug-of-abuse testing at the point of care.
Sensitive and specific assays are available to detect drugs of abuse at the point of care. This article describes the characteristics of point-of-care devices for drug-of-abuse testing with a focus on clinical utility and patient care. This article is not a comprehensive review of all available point-of-care devices. Instead, it discusses general principles of point-of-care testing for drugs of abuse.
Melanson
Stacy E F
SE
Division of Clinical Laboratories, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. semelanson@partners.org
D019983:Guideline Adherence; D017408:Guidelines as Topic; D006801:Humans; D013287:Illicit Drugs / Q000032:analysis* / Q000652:urine; D019095:Point-of-Care Systems; D015813:Substance Abuse Detection / Q000295:instrumentation / Q000379:methods*
D013287:Illicit Drugs